•
CR
CRL
Charles River Laboratories International, Inc.
polygonSERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
--
Price Chart
Market Cap
11.16B
Volume
204.91K
52W High
$228.88
52W Low
$91.86
Open
$228.39
Prev Close
$226.77
Day Range
223.76 - 228.39
About Charles River Laboratories International, Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
Latest News
Lead Optimization Services in Drug Discovery Market to Reach USD 10.26 Billion by 2034, Driven by Rising R&D Activity
GlobeNewswire Inc.•Nov 28
Innovative Drug CRO Market to Soar USD 96.06 Billion by 2035, Expanding at 5.44% CAGR
GlobeNewswire Inc.•Nov 28
Charles River Beat Expectations But Why Is The Stock Falling?
Benzinga•Nov 5
Cell-based Assays Market Size to Reach USD 35.34 Billion by 2032, Driven by Demand for Drug Discovery and Advanced Biotechnology Research – SNS Insider
GlobeNewswire Inc.•Oct 30
Cell & Gene Therapy Quality Control Market Poised USD 22.81 Billion at 25.74% CAGR by 2034
GlobeNewswire Inc.•Oct 29
Biologics Safety Testing Market to Rise at 13.64% CAGR, Soars USD 14.45 Bn by 2034
GlobeNewswire Inc.•Oct 16
Pharmaceutical Contract Research Services Market Report 2025-2035: M&A, Partnerships, and Biologics Focus
GlobeNewswire Inc.•Sep 24
Global Bioanalytical Testing Services Market to Observe Stunning Growth at a CAGR of ~16% by 2032 | DelveInsight
GlobeNewswire Inc.•Aug 26